Holding(s) in Company
2003年10月15日 - 7:43PM
RNSを含む英国規制内ニュース (英語)
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1) Name of company
XTL Biopharmaceuticals Limited
2) Name of shareholder having a major interest
Perpetual Income & Growth Investment Trust plc
3) Please state whether notification indicates that it is in
respect of holding of the shareholder named in 2 above or in
respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that person's spouse or
children under the age of 18
As 2 above
4) Name of the registered holder(s) and, if more than one holder,
the number of shares held by each of them
Vidacos Nominees Limited
5) Number of shares/amount of stock acquired
187,500 ordinary shares
6) Percentage of issued class
0.167%
7) Number of shares/amount of stock disposed
N/A
8) Percentage of issued class
N/A
9) Class of security
Ordinary shares of IIs0.02 each
10) Date of transaction
13 October 2003
11) Date company informed
14 October 2003
12) Total holding following this notification
4,597,715 shares
13) Total percentage holding of issued class following this
notification
4.10%
14) Any additional information
15) Name of contact and telephone number for queries
Jonathan Burgin, Chief Financial Officer +972 (0) 894 05134
16) Name and signature of authorised company official responsible
for making this notification
Jonathan Burgin
17) Date of notification
15 October 2003
END